IRWD logo

Ironwood Pharmaceuticals (IRWD) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

03 February 2010

Indexes:

Not included

Description:

Ironwood Pharmaceuticals (IRWD) is a biopharmaceutical company focused on developing and commercializing innovative treatments for gastrointestinal diseases. They aim to improve patients' lives through research and development of new therapies, particularly for conditions like irritable bowel syndrome and other digestive disorders.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Feb 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 02, 2019

Analyst ratings

Recent major analysts updates

09 Sept '24 Leerink Partners
Market Perform
09 Aug '24 Wells Fargo
Overweight
09 Aug '24 Craig-Hallum
Buy
10 May '24 Craig-Hallum
Buy
01 Mar '24 Wells Fargo
Overweight
16 Feb '24 Piper Sandler
Overweight
17 Jan '24 Craig-Hallum
Buy
14 Dec '23 Wells Fargo
Overweight
28 Sept '23 JMP Securities
Market Outperform
23 May '23 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
IRWD
zacks.com08 November 2024

IRWD's third-quarter earnings miss estimates while revenues beat the same. The company maintains revenue guidance for 2024.

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
IRWD
zacks.com07 November 2024

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.12 per share a year ago.

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
IRWD
businesswire.com24 October 2024

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its third quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 7, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 2530602. To access the webcast, please visit the Investors section of Ironwood's website at www.ir.

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
IRWD
zacks.com09 August 2024

Ironwood (IRWD) reports breakeven earnings for second-quarter 2024. Revenues miss estimates.

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
IRWD
zacks.com08 August 2024

Ironwood Pharmaceuticals (IRWD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.17. This compares to earnings of $0.31 per share a year ago.

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation
The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation
The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation
IRWD
accesswire.com28 June 2024

LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ironwood Pharmaceuticals, Inc. ("Ironwood" or "the Company") (NASDAQ:IRWD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue
The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue
The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue
IRWD
accesswire.com26 June 2024

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ironwood Pharmaceuticals, Inc. ("Ironwood" or "the Company") (NASDAQ:IRWD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact
The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact
The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact
IRWD
accesswire.com25 June 2024

LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ironwood Pharmaceuticals, Inc. ("Ironwood" or "the Company") (NASDAQ:IRWD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication
IRWD
accesswire.com24 June 2024

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ironwood Pharmaceuticals, Inc. ("Ironwood" or "the Company") (NASDAQ:IRWD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out
IRWD
accesswire.com22 June 2024

LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ironwood Pharmaceuticals, Inc. ("Ironwood" or "the Company") (NASDAQ:IRWD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

FAQ

  • What is the primary business of Ironwood Pharmaceuticals?
  • What is the ticker symbol for Ironwood Pharmaceuticals?
  • Does Ironwood Pharmaceuticals pay dividends?
  • What sector is Ironwood Pharmaceuticals in?
  • What industry is Ironwood Pharmaceuticals in?
  • What country is Ironwood Pharmaceuticals based in?
  • When did Ironwood Pharmaceuticals go public?
  • Is Ironwood Pharmaceuticals in the S&P 500?
  • Is Ironwood Pharmaceuticals in the NASDAQ 100?
  • Is Ironwood Pharmaceuticals in the Dow Jones?
  • When was Ironwood Pharmaceuticals's last earnings report?
  • When does Ironwood Pharmaceuticals report earnings?
  • Should I buy Ironwood Pharmaceuticals stock now?

What is the primary business of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals (IRWD) is a biopharmaceutical company focused on developing and commercializing innovative treatments for gastrointestinal diseases. They aim to improve patients' lives through research and development of new therapies, particularly for conditions like irritable bowel syndrome and other digestive disorders.

What is the ticker symbol for Ironwood Pharmaceuticals?

The ticker symbol for Ironwood Pharmaceuticals is NASDAQ:IRWD

Does Ironwood Pharmaceuticals pay dividends?

No, Ironwood Pharmaceuticals does not pay dividends

What sector is Ironwood Pharmaceuticals in?

Ironwood Pharmaceuticals is in the Healthcare sector

What industry is Ironwood Pharmaceuticals in?

Ironwood Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Ironwood Pharmaceuticals based in?

Ironwood Pharmaceuticals is headquartered in United States

When did Ironwood Pharmaceuticals go public?

Ironwood Pharmaceuticals's initial public offering (IPO) was on 03 February 2010

Is Ironwood Pharmaceuticals in the S&P 500?

No, Ironwood Pharmaceuticals is not included in the S&P 500 index

Is Ironwood Pharmaceuticals in the NASDAQ 100?

No, Ironwood Pharmaceuticals is not included in the NASDAQ 100 index

Is Ironwood Pharmaceuticals in the Dow Jones?

No, Ironwood Pharmaceuticals is not included in the Dow Jones index

When was Ironwood Pharmaceuticals's last earnings report?

Ironwood Pharmaceuticals's most recent earnings report was on 7 November 2024

When does Ironwood Pharmaceuticals report earnings?

The next expected earnings date for Ironwood Pharmaceuticals is 14 February 2025

Should I buy Ironwood Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions